Core Viewpoint - The company plans to raise a total of 1.291 billion yuan through a non-public offering of shares to specific investors, with the funds allocated for various projects related to precious metals and working capital [2][3]. Financing Details - The financing amount is set at 1.291 billion yuan, with the acceptance date for the offering being October 30, 2025 [2]. - The offering will target no more than 35 specific investors, including qualified institutional investors and individuals as defined by the China Securities Regulatory Commission [2]. Share Issuance - The pricing benchmark for the share issuance will be the first day of the offering period, with the issue price not lower than 80% of the average trading price over the previous 20 trading days [3]. - The shares to be issued are domestic listed RMB ordinary shares (A-shares) with a par value of 1.00 yuan each, and the total number of shares issued will not exceed 30% of the total share capital prior to the issuance, amounting to a maximum of 227,942,137 shares [3]. Fund Allocation - The raised funds will be allocated to several projects, including: - National Key Laboratory Platform for Precious Metal Functional Materials: 400 million yuan - AI Laboratory for Precious New Materials: 84 million yuan - Modern Industrial Base for Precious Metal Secondary Resource Enrichment: 170 million yuan - Green Recycling Base for Precious Metal Secondary Resources: 130 million yuan - Deep Processing and Intelligent Upgrading of Precious Metal Alloy Functional New Materials: 80 million yuan - Industrialization of Platinum Anticancer Drug Raw Materials: 40 million yuan - Working Capital Supplement: 387 million yuan - The total investment for these projects is approximately 2.5318187 billion yuan, with the fundraising amount capped at 1.291 billion yuan [4]. Shareholder Structure - As of the date of the fundraising prospectus, the company has not determined the specific investors for the issuance, and the maximum number of shares issued will not change the company's control structure [5]. - The company is controlled by Yunnan Provincial State-owned Assets Supervision and Administration Commission, with Yuntou Group holding 38.60% of the shares [5].

Group 1 - The core point of the news is that Guiyan Platinum Industry has approved a plan to issue shares to specific investors, aiming to raise up to 1.291 billion yuan for various projects [1] - The share issuance will involve no more than 35 specific investors and will not exceed 30% of the total share capital prior to the issuance, amounting to approximately 228 million shares [1] - The funds raised will be allocated to several projects, including the construction of a key laboratory platform for precious metal functional materials, an AI laboratory for new materials, and various recycling and processing projects [1] Group 2 - For the first half of 2025, the revenue composition of Guiyan Platinum Industry includes 36.21% from precious metal recycling materials, 35.17% from precious metal trading, 16.05% from special functional materials, 8.65% from precursor materials, and 3.01% from automotive catalytic purifiers [2] - As of the latest report, the market capitalization of Guiyan Platinum Industry is 12.3 billion yuan [3]

Core Viewpoint - Guiyan Platinum Industry (600459.SH) announced a plan to issue A-shares to specific investors, aiming to raise no more than 1.291 billion yuan for various projects [1] Fundraising and Investment Projects - The total amount to be raised from the issuance of A-shares is capped at 1.291 billion yuan, including the principal amount [1] - The raised funds will be allocated to several key projects, including: - Construction of a national key laboratory platform for precious metal functional materials - Establishment of an AI laboratory for new precious metal materials - Development of a modern industrial base for the recycling of secondary precious metal resources - Green recycling project for secondary precious metal resources - Deep processing and intelligent upgrading of new functional alloys - Industrialization of platinum-based anticancer drug raw materials - Supplementing working capital [1]